About 2 results found for searched term "Nivolumab" (0.187 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6100 | Nivolumab | PD-1/PD-L1 |
| BMS-936558, ONO-4538, MDX-1106；Opdivo | ||
| Nivolumab (nabumab) is a fully humanized IgG4 monoclonal antibody against PD-1. It has immune checkpoint inhibitory activity and antitumor activity; MW: 143.597 KD.(for human-derived mice). | ||
| M24735 | Cabiralizumab | CSF-1R (c-Fms) |
| FPA 008; Anti-Human CSF1R Recombinant Antibody | ||
| Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab for lung cancer research. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
